Harrow Financial Statements From 2010 to 2024
| HROWL Stock | USD 25.43 0.08 0.32% |
Check Harrow Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Harrow Health's main balance sheet or income statement drivers, such as , as well as many indicators such as . Harrow financial statements analysis is a perfect complement when working with Harrow Health Valuation or Volatility modules.
Harrow |
Harrow Health 8625 Company Revenue Analysis
Harrow Health's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current Harrow Health Revenue | 130.19 M |
Most of Harrow Health's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Harrow Health 8625 is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
Based on the latest financial disclosure, Harrow Health 8625 reported 130.19 M of revenue. This is much higher than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The revenue for all United States stocks is notably lower than that of the firm.
Harrow Health 8625 Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Harrow Health's current stock value. Our valuation model uses many indicators to compare Harrow Health value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Harrow Health competition to find correlations between indicators driving Harrow Health's intrinsic value. More Info.Harrow Health 8625 is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in number of shares shorted category among its peers making about 1,599 of Number Of Shares Shorted per Return On Equity. Comparative valuation analysis is a catch-all technique that is used if you cannot value Harrow Health by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.About Harrow Health Financial Statements
Harrow Health investors utilize fundamental indicators, such as revenue or net income, to predict how Harrow Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out the analysis of Harrow Health Correlation against competitors. For more information on how to buy Harrow Stock please use our How to buy in Harrow Stock guide.You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Harrow Health. If investors know Harrow will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Harrow Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Harrow Health 8625 is measured differently than its book value, which is the value of Harrow that is recorded on the company's balance sheet. Investors also form their own opinion of Harrow Health's value that differs from its market value or its book value, called intrinsic value, which is Harrow Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Harrow Health's market value can be influenced by many factors that don't directly affect Harrow Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Harrow Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Harrow Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Harrow Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.